Kestrel Group Reports Second Quarter 2026 Financial Results
Go back to Kestrel Group Reports Second Quarter 2026 Financial Results| KING PHARMACEUTICALS (NASDAQ: KG) | Delayed: 8.14 +0.15 (1.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.99 | 52 Week High | $14.26 | |||
| Open | $7.75 | 52 Week Low | $7.18 | |||
| Day High | $8.14 | P/E | 23.94 | |||
| Day Low | $7.75 | EPS | $0.34 | |||
| Volume | 8,064 | |||||
